The Pancreatitis drugs in development market research report provides comprehensive information on the therapeutics under development for Pancreatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Pancreatitis. Buy the report here.

The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Pancreatitis and features dormant and discontinued products.

GlobalData tracks 42 drugs in development for Pancreatitis by 34 companies/universities/institutes. The top development phase for Pancreatitis is preclinical with 25 drugs in that stage. The Pancreatitis pipeline has 37 drugs in development by companies and five by universities/ institutes. Some of the companies in the Pancreatitis pipeline products market are: CalciMedica, LipimetiX Development and Daewoong Pharmaceutical.

The key targets in the Pancreatitis pipeline products market include Peptidyl Prolyl Cis Trans Isomerase (EC, ORAI Calcium Release Activated Calcium Modulator (ORAI), and Low Density Lipoprotein Receptor (LDLR).

The key mechanisms of action in the Pancreatitis pipeline product include Kynurenine 3 Monooxygenase (Kynurenine 3 Hydroxylase or KMO or EC Inhibitor with two drugs in Phase I. The Pancreatitis pipeline products include five routes of administration with the top ROA being Intravenous and seven key molecule types in the Pancreatitis pipeline products market including Small Molecule, and Cell Therapy.

Pancreatitis overview

Pancreatitis is an inflammation of the pancreas. Symptoms include nausea, vomiting, tenderness when touching the abdomen, weight loss, and upper abdominal pain. Predisposing factors include alcoholism, smoking, family history of pancreatitis, infection, injury to the abdomen, and pancreatic cancer. Treatment includes antibiotics and medication to relieve pain.

For a complete picture of Pancreatitis’s pipeline drug market, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.